WaveMan
WaveMan · Company
PCYN · Procyon Corp
> Search tickers & screens ⌘K
LIVE
← All companies

PCYN Procyon (PCYN) Insider Trading, Ownership & Congress Trades

Pharma & Biotech · Pharmaceutical preparations · CIK 0000812306
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter

Procyon insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for PROCYON CORP in the period covered. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
SPEER FOUNDATION
SELL
2024-06-27 SECtraded 2024-06-26
40,000
$7.2K
-19.6%
Context
  • 4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Jun 25, 2024.
  • The trade is 2.9% of the 1,380,000 shares held after it.
  • No other insider sold within 30 days.
Insider activity: Insider SPEER FOUNDATION sold about $7.2K of PCYN on Jun 26, 2024.
SPEER FOUNDATION
SELL
2024-06-27 SECtraded 2024-06-25
40,000
$7.6K
-19.6%
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Mar 31, 2022.
  • The trade is 2.8% of the 1,420,000 shares held after it.
  • No other insider sold within 30 days.
Insider activity: Insider SPEER FOUNDATION sold about $7.6K of PCYN on Jun 25, 2024, the largest insider sale at the company since 2022.
SPEER FOUNDATION
SELL
2022-04-01 SECtraded 2022-03-31
40,000
$15.2K
-58.9%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Feb 7, 2022.
  • The trade is 2.7% of the 1,460,000 shares held after it.
  • No other insider sold within 30 days.
Insider activity: Insider SPEER FOUNDATION sold about $15.2K of PCYN on Mar 31, 2022, the largest insider sale at the company on our record.
SPEER FOUNDATION
SELL
2022-02-08 SECtraded 2022-02-07
15,000
$5.2K
-48.0%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Dec 6, 2021.
  • The trade is 1.0% of the 1,500,000 shares held after it.
  • No other insider sold within 30 days.
Insider activity: Insider SPEER FOUNDATION sold about $5.2K of PCYN on Feb 7, 2022.
SPEER FOUNDATION
SELL
2021-12-07 SECtraded 2021-12-06
25,000
$8.0K
-47.1%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 1.7% of the 1,515,000 shares held after it.
  • No other insider sold within 30 days.
Insider activity: Insider SPEER FOUNDATION sold about $8.0K of PCYN on Dec 6, 2021, the largest insider sale at the company on our record.
5 transactions on record · a thin record, read with care
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
+6.4% year over year
more than 55% of Pharma & Biotech
Margin
-6.8% net margin
more than 67% of Pharma & Biotech
Buybacks
no share repurchases reported
Short interest
no short interest reported
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch PCYN

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+52.9%12M
+0%+44%+88%+131%2025-102025-122026-022026-042026-062026-082026-10
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns PCYN: institutional holders (13F)

13F holdings, latest reported quarter
SEC 13F
No reported 13F holders

No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.

Congress trades in PCYN

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

PCYN planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
Each figure here is a federal filing, dated the day it went public, so you can test what was knowable then.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
UTHRCPIXMRNAREGNLLYALNYMDGLCITRDNAVRTXNUVLTWST

PCYN financials

Revenue growth
+6.4%
XBRL, annual
Net margin
-6.8%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$5.0M
four quarters, 2023-07-01 to 2024-06-30
Net margin, TTM
-6.8%
net income over revenue, 2023-07-01 to 2024-06-30
Free cash flow, TTM
-$125.2K
operating cash flow minus capex, 2023-07-01 to 2024-06-30
Debt to equity
n/a
no debt line filed
Cash flow to debt
n/a
no debt line filed
Return on equity
-13.9%
TTM net income over average of 2023-06-30 and 2024-06-30
Return on assets
-10.1%
TTM net income over average of 2023-06-30 and 2024-06-30
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on capital employed
-8.6%
operating income (EBIT proxy) over average of 2023-06-30 and 2024-06-30 minus current liabilities
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
n/a
no debt line filed
FCF yield
-8.3%
TTM free cash flow over market value at close 2026-10-23
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2024-062023-062022-062021-06
Revenue$5.0M$4.7M$4.8M$4.7M
Gross profit$3.9M$3.6M$3.5M$3.4M
Operating income-$231.7K-$97.4K-$237.2K$226.7K
Net income-$341.1K-$50.2K-$209.8K$694.3K
EPS (diluted)-0.04-0.01-0.030.08
Operating cash flow-$61.3K$145.5K-$383.5K$279.5K
SEC XBRL, fiscal years, as known on 2026-10-27

PCYN Stock Sonar score 2/7 axes

Find similar shapesCompare
Profitability
76
Inputs
  • Return on equity-13.9% · 75 pct, sector of 545
  • Return on assets-10.1% · 74 pct, sector of 691
  • Return on invested capitalpre-tax loss, no effective tax rate to apply
  • Return on capital employed-8.6% · 80 pct, sector of 576
Growth
55
Inputs
  • Revenue growth, YoY+6.4% · 55 pct, sector of 505
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
5 not measured: Financial health, Insider conviction, Institutional and government, Risk and compliance, US patents
  • Financial health needs 1 of 2 inputs, 0 present: no debt line filed
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • Risk and compliance needs 1 of 4 inputs, 0 present: needs two 10-Ks with a Risk Factors section (not 20-F filers or stubs); no short interest or no free float on file; revenue under $50M or not filed, so a count cannot be scaled to size
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

2 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies